Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Associations of vomiting and antiemetic use in pregnancy with levels of circulating GDF15 early in the second trimester: A nested case-control study
Clive J. Petry, Ken K. Ong, Keith Burling, et al.
Wellcome Open Research (2018) Vol. 3, pp. 123-123
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Dongdong Wang, Emily A. Day, Logan K. Townsend, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 10, pp. 592-607
Closed Access | Times Cited: 312
Nausea and vomiting of pregnancy and hyperemesis gravidarum
Marlena S. Fejzo, Jone Trovik, Iris J. Grooten, et al.
Nature Reviews Disease Primers (2019) Vol. 5, Iss. 1
Closed Access | Times Cited: 204
GDF15: A Hormone Conveying Somatic Distress to the Brain
Sam Lockhart, Vladimı́r Saudek, Stephen O’Rahilly
Endocrine Reviews (2020) Vol. 41, Iss. 4
Open Access | Times Cited: 165
Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems
Weixia Zhong, Omar Shahbaz, Garrett Teskey, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5797-5797
Open Access | Times Cited: 146
The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
Samuel N. Breit, David A. Brown, Vicky Wang-Wei Tsai
Annual Review of Physiology (2020) Vol. 83, Iss. 1, pp. 127-151
Closed Access | Times Cited: 141
GDF15 linked to maternal risk of nausea and vomiting during pregnancy
Marlena S. Fejzo, Nuno Rocha, Irène Cimino, et al.
Nature (2023) Vol. 625, Iss. 7996, pp. 760-767
Open Access | Times Cited: 78
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
Olivier Bénichou, Tamer Coşkun, Malgorzata D. Gonciarz, et al.
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 274-286.e10
Open Access | Times Cited: 52
GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss
Tito Borner, Hallie S. Wald, Misgana Y. Ghidewon, et al.
Cell Reports (2020) Vol. 31, Iss. 3, pp. 107543-107543
Open Access | Times Cited: 74
The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling
Amy A. Worth, Rosemary Shoop, Katie Tye, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 71
Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation
Ying Wang, Chaojie Chen, Jiajun Chen, et al.
Redox Biology (2022) Vol. 52, pp. 102322-102322
Open Access | Times Cited: 66
Hindbrain circuits in the control of eating behaviour and energy balance
Wenwen Cheng, Desiree Gordian, Mette Q. Ludwig, et al.
Nature Metabolism (2022) Vol. 4, Iss. 7, pp. 826-835
Closed Access | Times Cited: 63
GFRAL-expressing neurons suppress food intake via aversive pathways
Paul V. Sabatini, Henriette Frikke‐Schmidt, Joe Arthurs, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 8
Open Access | Times Cited: 62
The windsor definition for hyperemesis gravidarum: A multistakeholder international consensus definition
Larissa A.W. Jansen, Marjette H. Koot, Janneke van ‘t Hooft, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology (2021) Vol. 266, pp. 15-22
Open Access | Times Cited: 56
Emerging Progress in Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum: Challenges and Opportunities
Chuan Liu, Zhao Guo, Danni Qiao, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 43
Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis
Gareth J. Sanger, Paul Andrews
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 9, pp. 962-978
Open Access | Times Cited: 23
Blood mitochondrial health markers cf-mtDNA and GDF15 in human aging
Caroline Trumpff, Qiuhan Huang, Jeremy Michelson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality
Marlena S. Fejzo, Peter A. Fasching, Michael Schneider, et al.
Geburtshilfe und Frauenheilkunde (2019) Vol. 79, Iss. 04, pp. 382-388
Open Access | Times Cited: 57
Whole‐exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum
Marlena S. Fejzo, Kimber MacGibbon, Olivia First, et al.
BJOG An International Journal of Obstetrics & Gynaecology (2022) Vol. 129, Iss. 11, pp. 1845-1852
Open Access | Times Cited: 32
Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis
Jojo Reyes, George Yap
The Journal of Immunology (2023) Vol. 210, Iss. 1, pp. 5-11
Closed Access | Times Cited: 21
GDF15 enhances body weight and adiposity reduction in obese mice by leveraging the leptin pathway
Samuel N. Breit, Rakesh Manandhar, Hongping Zhang, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1341-1355.e3
Open Access | Times Cited: 18
Hyperemesis gravidarum theories dispelled by recent research: a paradigm change for better care and outcomes
Marlena S. Fejzo
Trends in Molecular Medicine (2024) Vol. 30, Iss. 6, pp. 530-540
Open Access | Times Cited: 7
Growth differentiation factor 15 as a potential therapeutic for treating obesity
Clarence Hale, Murielle M. Véniant
Molecular Metabolism (2020) Vol. 46, pp. 101117-101117
Open Access | Times Cited: 42
GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander?
Anders B. Klein, Maximilian Kleinert, Erik A. Richter, et al.
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 38
Growth‐differentiation‐factor 15 levels in obese and healthy pregnancies: Relation to insulin resistance and insulin secretory function
Ulrika Andersson, Louise Joelsson, Pernilla Svedin, et al.
Clinical Endocrinology (2021) Vol. 95, Iss. 1, pp. 92-100
Open Access | Times Cited: 36
Insufficient GDF15 expression predisposes women to unexplained recurrent pregnancy loss by impairing extravillous trophoblast invasion
Chunzi Lyu, Tianxiang Ni, Yaqiu Guo, et al.
Cell Proliferation (2023) Vol. 56, Iss. 12
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top